Abstract
In a new report, Nyati et al. identified a previously undetected participant mediating both canonical signaling, i.e., TGF-β receptor kinase mediated, and non-canonical signaling, budding uninhibited by benzimidazole 1 (BUB1).
Cite
CITATION STYLE
APA
Barcellos-Hoff, M. H. (2015, February 1). BUB1-bling over with Possibilities. Neoplasia (United States). Elsevier Inc. https://doi.org/10.1016/j.neo.2015.01.002
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free